author-photo

Francisco A. Kerdel

University of Miami

228

Papers

5999

Citations

Citation Trend

Filter By

Papers (228) Sort By

Journal Conference Others

Three-year U.S. pharmacovigilance report of brodalumab.

2021 Dermatologic Therapy
Show All
- Source
- Cite
- Save
Citations (0)
Dr. Francisco Kerdel-Vegas (1928-2020)

2021
- Francisco A. Kerdel
Show All
- Source
- Cite
- Save
Citations (0)
16525 Long-term efficacy and safety in clinical trials of brodalumab by prior response to adalimumab

2020 Journal of The American Academy of Dermatology
Show All
- Source
- Cite
- Save
Citations (0)
15144 Long-term safety of apremilast treatment in patients with psoriasis or psoriatic arthritis: Pooled analysis for 260 weeks and beyond in the ESTEEM 1 and 2 and PALACE 1-4 phase 3 trials

2020 Journal of The American Academy of Dermatology
Show All
- Source
- Cite
- Save
Citations (0)
Erosive pustular dermatosis after CO 2 laser resurfacing in mother and daughter

2020 Dermatologic Therapy
Show All
- Source
- Cite
- Save
Citations (0)
A Phase II, Open Label Study of Bermekimab in Patients with Hidradenitis Suppurativa Shows Resolution of Inflammatory Lesions and Pain

2020 Journal of Investigative Dermatology
Show All
- Source
- Cite
- Save
Citations (26)
Lichenoid drug eruption after treatment with ixekizumab for plaque psoriasis.

2020 Dermatology Online Journal
Show All
- Source
- Cite
- Save
Citations (0)
Emerging drugs for the treatment of Hidradenitis Suppurativa

2020 Expert Opinion on Emerging Drugs
Show All
- Source
- Cite
- Save
Citations (4)
Baseline Characteristics from UNITE: An Observational, International, Multicentre Registry to Evaluate Hidradenitis Suppurativa (Acne Inversa) in Clinical Practice

2020 American Journal of Clinical Dermatology
Show All
- Source
- Cite
- Save
Citations (5)
Apremilast for the Treatment of Mild-to-Moderate Hidradenitis Suppurativa in a Prospective, Open-Label, Phase 2 Study

2019 Journal of Drugs in Dermatology
Show All
- Source
- Cite
- Save
Citations (14)